Clinical Trial Update: Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ramosetron for prevention of intrathecal morphine–induced postoperative nausea and vomiting after surgery. The trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Ramosetron (ramosetron)

Snippet

Sponsor: Thammasat University | Conditions: Postoperative Nausea and Vomiting | Phase 3 | Status: COMPLETED